Sippican Capital Advisors Merck & Co., Inc. Transaction History
Sippican Capital Advisors
- $139 Million
- Q3 2025
A detailed history of Sippican Capital Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sippican Capital Advisors holds 23,126 shares of MRK stock, worth $2.15 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
23,126
Previous 22,183
4.25%
Holding current value
$2.15 Million
Previous $1.76 Million
10.48%
% of portfolio
1.39%
Previous 1.37%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,875Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...